Encephalopathy is the dose-limiting toxicity of intravenous hepsulfam: results of a phase I trial in patients with advanced hematological malignancies

Richard A. Larson, Robert B. Geller, Linda Janisch, John Milton, Louise B. Grochow, Mark J. Ratain

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Encephalopathy is the dose-limiting toxicity of intravenous hepsulfam: results of a phase I trial in patients with advanced hematological malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds